Ads
related to: Novavax
Search results
Short Interest in Novavax, Inc. (NASDAQ:NVAX) Drops By 15.6%
ETF DAILY NEWS· 6 days agoNovavax, Inc. (NASDAQ:NVAX – Get Free Report) was the recipient of a significant decline in short interest during the month of May. As of May 31st, there was short interest ...
Is It Too Late to Buy Novavax Stock?
The Motley Fool via AOL· 7 days agoNovavax (NASDAQ: NVAX) stock is suddenly a buy again this year, with its stock price more than tripling since the start of 2024. Some positive developments in recent months ...
Novavax’s South African Phase IIb COVID-19 vaccine trial likely to reveal results within next...
Pharmaceutical Technology via Yahoo Finance· 3 days agoSouth Africa’s existing regulatory, consent and ethics frameworks around HIV vaccine trial investigations helped with regards to quick initiation and straightforward progress of COVID-19 vaccine trials in the country, the source said.
COVID vaccine companies told to focus on KP.2 variant for fall shots, per FDA announcement
Fox News· 5 days agoThe U.S. Food and Drug Administration (FDA) has recommended that COVID vaccine manufacturers update...
Is Moderna Stock A Buy After Its Second-Ever Product Snags FDA Approval?
Investor's Business Daily· 5 hours agoThe company noted that it achieved 48% market share for Covid vaccines in the U.S. during the fall...
FDA modifies strain recommendation for fall COVID vaccine amid variant shifts, uptick in cases
Center for Infectious Disease Research and Policy· 6 days agoOn June 5, the FDA's vaccine advisory group recommended a switch to the JN.1 variant, though it held...
FDA asks COVID vaccine makers to target KP.2 strain, if feasible, for next shot
Reuters via Yahoo News· 6 days agoThe Food and Drug Administration's change in recommendation, in an update dated Thursday, comes even...
3 Short-Squeeze Stocks Ready to Break the Chains of Bearish Sentiment
InvestorPlace· 2 days agoIt was not long ago that Novavax (NASDAQ:NVAX) was among the stocks with high short interest. In the...
Novavax applies for FDA nod for its updated COVID vaccine
Center for Infectious Disease Research and Policy· 3 days agoThe company said it will have the vaccine ready to distribute in mid July as prefilled syringes, pending approval and recommendations.
Texas Biomed expanding animal research complex with $20 million building
San Antonio Express-News· 13 hours agoThe Texas Biomedical Research Institute is continuing expansion of a new animal research complex on...
